Synovus Financial Corp Armata Pharmaceuticals, Inc. Transaction History

Synovus Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$3.9 - $6.32 $514 - $834	-132 Reduced 0.27%	47,903 $235,000
Q4 2021 Feb 14, 2022	SELL	$2.96 - $5.86 $74 - $146	-25 Reduced 0.05%	48,035 $263,000
Q3 2021 Nov 08, 2021	BUY	$3.55 - $4.14 $88,750 - $103,499	25,000 Added 108.41%	48,060 $174,000
Q2 2021 Aug 11, 2021	BUY	$3.89 - $4.87 $89,703 - $112,302	23,060 New	23,060 $91,000

1.42M

200

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $96.5M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.